Intensive Care Medicine

, Volume 31, Issue 1, pp 164–165 | Cite as

Levosimendan in septic cardiac failure

  • A. Noto
  • M. Giacomini
  • A. Palandi
  • L. Stabile
  • C. Reali-Forster
  • G. Iapichino
Correspondence

References

  1. 1.
    Dellinger RP, Carret JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmermann J, Vincent JL, Levy MM (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 30:536–555CrossRefPubMedGoogle Scholar
  2. 2.
    Behrends M, Peters J (2003) The calcium sensitizer levosimendan attenuates endotoxin-evoked myocardial dysfunction in isolated guinea pig hearts. Intensive Care Med 29:1802–1807CrossRefPubMedGoogle Scholar
  3. 3.
    Oldner A, Konrad D, Weitzberg E, Rudehill A, Rossi P, Wanecek M (2001) Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock. Crit Care Med 29:2185–2193CrossRefPubMedGoogle Scholar
  4. 4.
    Mc Lean A, Huang D, Stewart D, Nalos M, Tang B (2004) Efficacy of levosimendan in shock. Crit Care Med 8(Suppl 1):P83CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • A. Noto
    • 1
  • M. Giacomini
    • 1
  • A. Palandi
    • 1
  • L. Stabile
    • 1
  • C. Reali-Forster
    • 1
  • G. Iapichino
    • 1
  1. 1.Istituto di Anestesiologia e Rianimazione dell’Università degli Studi di MilanoAzienda Ospedaliera-Polo Universitario San PaoloMilanoItaly

Personalised recommendations